In transgenic mouse models of Alzheimer’s disease KV1.3 blockade decreased cerebral amyloid load, enhanced hippocampal neuronal plasticity, and improved behavioral deficits [7]. This evidence concerns the gene KCNA3 and early-onset autosomal dominant Alzheimer disease.